Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

NCT00744081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

DRUG: Glivec
DRUG: Mitoxantrone
DRUG: Topotecan
DRUG: AraC

Sponsor

Goethe University